David M Mott's Net Worth

David M Mott's net worth is estimated to be at least $35,641,915.66 as of 12/27/2024. CoreStreet's estimation of David M Mott's net worth is based on their sale of stock and current holding of stock.

David M Mott is Director at Ardelyx Inc. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 213,300 units of ARDX stock on 12/19/2024. Their biggest sale was on 09/23/2021 when they sold 24,961 units of Novavax Inc stock for $6,312,636.90. They typically trade 1 times per year.

Total value of insider buys:
  • $27,956,611.24
Total value of insider sells:
  • $7,685,304.42
Most recent insider trade:
  • Dec. 19, 2024

David M Mott's Insider Trading History

Ardelyx IncTitleAmountPriceTypeTotal Value
Dec. 19, 2024
Director213,300$4.67Buy$996,111.00
Imara IncTitleAmountPriceTypeTotal Value
Feb. 22, 2022
Director65,817$1.56Buy$102,674.52
Feb. 18, 2022
Director50,398$1.30Buy$65,517.40
Feb. 16, 2022
Director11,779$1.20Buy$14,134.80
Feb. 14, 2022
Director8,500$1.18Buy$10,030.00
Feb. 10, 2022
Director8,753$1.29Buy$11,291.37
Novavax IncTitleAmountPriceTypeTotal Value
Sept. 23, 2021
Director24,961$252.90Sell$6,312,636.90
Epizyme IncTitleAmountPriceTypeTotal Value
March 25, 2021
Director28,231$7.98Buy$225,283.38
June 26, 2020
Director62,019$16.03Buy$994,164.57
June 26, 2019
Director104,944$13.08Sell$1,372,667.52
Oct. 5, 2018
Director416,667$9.00Buy$3,750,003.00
Sept. 18, 2017
Director200,000$15.25Buy$3,050,000.00
Jan. 12, 2016
Director1,111,111$9.00Buy$9,999,999.00
June 5, 2013
Director400,000$15.00Buy$6,000,000.00
Adaptimmune Therapeutics PlcTitleAmountPriceTypeTotal Value
March 26, 2018
Director571,164$1.90Buy$1,085,211.60
March 22, 2018
Director869,574$1.90Buy$1,652,190.60